Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension

Circulation: Heart Failure

Volumn 5, Issue 1, 2012, Pages 97-105

  De Man, Frances S ^a   Handoko, M Louis ^a,b   Van Ballegoij, Joris J M ^a,b   Schalij, Ingrid ^a   Bogaards, Sylvia J P ^a,b   Postmus, Pieter E ^a   Van Der Velden, Jolanda ^b   Westerhof, Nico ^b   Paulus, Walter J ^b   Vonk Noordegraaf, Anton ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

adrenergic receptor blocker; Pressure volume relationship; Pulmonary hypertension; Right ventricular dysfunction; Wistar rats

Indexed keywords

BETA ADRENERGIC RECEPTOR; BISOPROLOL; MONOCROTALINE; ANTIHYPERTENSIVE AGENT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; DRUG MECHANISM; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART RATE; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE PRESSURE; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; NONHUMAN; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; ECHOGRAPHY; FIBROSIS; HEART FAILURE; HEART VENTRICLE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BISOPROLOL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FIBROSIS; HEART FAILURE; HEART VENTRICLES; HYPERTENSION, PULMONARY; MALE; MONOCROTALINE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; VASCULAR RESISTANCE;

EID: 84859628413     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.111.964494     Document Type: Article

References (36)

1. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34:1219-1263.
2. Ghofrani HA, Barst RJ, Benza RL, Champion HC, Fagan KA, Grimminger F, Humbert M, Simonneau G, Stewart DJ, Ventura C, Rubin LJ. Future perspectives for the treatment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S108-S117.
3. Handoko ML, de Man FS, Allaart CP, Paulus WJ, Westerhof N, Vonk- Noordegraaf A. Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: Lessons from the left heart. Eur Respir Rev. 2010;19:72-82.
4. McGowan CL, Swiston JS, Notarius CF, Mak S, Morris BL, Picton PE, Granton JT, Floras JS. Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension. Heart. 2009;95:754-758.
5. Velez-Roa S, Ciarka A, Najem B, Vachiery JL, Naeije R, van de Borne P. Increased sympathetic nerve activity in pulmonary artery hypertension. Circulation. 2004;110:1308-1312. (Pubitemid 39202350)
6. Wensel R, Jilek C, Dorr M, Francis DP, Stadler H, Lange T, Blumberg F, Opitz C, Pfeifer M, Ewert R. Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension. Eur Respir J. 2009;34: 895-901.
7. Ciarka A, Doan V, Velez-Roa S, Naeije R, van de Borne P. Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2010;181:1269-1275.
8. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest. 1992;89:803-815.
9. Handoko ML, de Man FS, Happe CM, Schalij I, Musters RJ, Westerhof N, Postmus PE, Paulus WJ, van der Laarse WJ, Vonk-Noordegraaf A. Opposite effects of training in rats with stable and progressive pulmonary hypertension. Circulation. 2009;120:42-49.
10. Bristow MR. Beta-adrenergic receptor blockade in chronic heart failure. Circulation. 2000;101:558-569. (Pubitemid 30080872)
11. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119: E391-e479.
12. Provencher S, Chemla D, Herve P, Sitbon O, Humbert M, Simonneau G. Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension. Eur Respir J. 2006;27:114-120. (Pubitemid 43092674)
13. Brimioulle S, Wauthy P, Ewalenko P, Rondelet B, Vermeulen F, Kerbaul F, Naeije R. Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol. 2003; 284:H1625-H1630. (Pubitemid 36460775)
14. Provencher S, Herve P, Jais X, Lebrec D, Humbert M, Simonneau G, Sitbon O. Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension. Gastroenterology. 2006;130:120-126. (Pubitemid 43049842)
15. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with betaadrenergic blockade. J Am Coll Cardiol. 1995;25:1154-1161.
16. Bogaard HJ, Natarajan R, Mizuno S, Abbate A, Chang PJ, Chau VQ, Hoke NN, Kraskauskas D, Kasper M, Salloum FN, Voelkel NF. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am J Respir Crit Care Med. 2010;182:652-660.
17. Hemnes AR, Kawut SM. The right ventricle in pulmonary hypertension: From dogma to data. Am J Respir Crit Care Med. 2010;182:586-588.
18. Handoko ML, Lamberts RR, Redout EM, de Man FS, Boer C, Simonides WS, Paulus WJ, Westerhof N, Allaart CP, Vonk-Noordegraaf A. Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: A study in the isolated heart. Am J Physiol Heart Circ Physiol. 2009;297:H1752-H1759.
19. Handoko ML, Schalij I, Kramer K, Sebkhi A, Postmus PE, van der Laarse WJ, Paulus WJ, Vonk-Noordegraaf A. A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: A useful tool in pulmonary hypertension research. Pflugers Arch. 2008; 455:951-959. (Pubitemid 350265617)
20. Westerhof N, Stergiopulos N, and Noble MIM. Snapshots of Hemdynamics: An Aid for Clinical Research and Graduate Education. New York, NY: Springer; 2010.
21. Hessel MH, Steendijk P, den Adel B, Schutte CI, van der Laarse A. Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat. Am J Physiol Heart Circ Physiol. 2006;291:H2424-H2430.
22. Suga H, Sagawa K, Shoukas AA. Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res. 1973;32:314-322.
23. Karunanithi MK, Michniewicz J, Copeland SE, Feneley MP. Right ventricular preload recruitable stroke work, end-systolic pressure-volume, and dP/dtmax-end-diastolic volume relations compared as indexes of right ventricular contractile performance in conscious dogs. Circ Res. 1992;70:1169-1179.
24. de Man FS, Handoko ML, Groepenhoff H, van't Hul AJ, Abbink J, Koppers RJ, Grotjohan HP, Twisk JW, Bogaard HJ, Boonstra A, Postmus PE, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A. Effects of exercise training in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2009;34:669-675.
25. Zaremba R, Merkus D, Hamdani N, Lamers JM, Paulus WJ, Dos RC, Duncker DJ, Stienen GJ, van d V. Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies. Proteomics Clin Appl. 2007;1:1285-1290.
26. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: A guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol. 2005;289:H501-H512. (Pubitemid 41129360)
27. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol. 2009;54: 1747-1762.
28. McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW. Meta-analysis: Beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med. 2009;150:784-794.
29. Nishio M, Sakata Y, Mano T, Ohtani T, Takeda Y, Miwa T, Hori M, Masuyama T, Kondo T, Yamamoto K. Beneficial effects of bisoprolol on the survival of hypertensive diastolic heart failure model rats. Eur J Heart Fail. 2008;10:446-453.
30. Usui S, Yao A, Hatano M, Kohmoto O, Takahashi T, Nagai R, Kinugawa K. Upregulated neurohumoral factors are associated with left ventricular remodeling and poor prognosis in rats with monocrotaline-induced pulmonary arterial hypertension. Circ J. 2006;70:1208-1215. (Pubitemid 44387006)
31. Ishikawa M, Sato N, Asai K, Takano T, Mizuno K. Effects of a pure alpha/beta-adrenergic receptor blocker on monocrotaline-induced pulmonary arterial hypertension with right ventricular hypertrophy in rats. Circ J. 2009;73:2337-2341.
32. Iaccarino G, Tomhave ED, Lefkowitz RJ, Koch WJ. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. Circulation. 1998;98: 1783-1789. (Pubitemid 28492500)
33. Lohse MJ, Engelhardt S, Eschenhagen T. What is the role of betaadrenergic signaling in heart failure? Circ Res. 2003;93:896-906. (Pubitemid 37433227)
34. Sun M, Chen M, Dawood F, Zurawska U, Li JY, Parker T, Kassiri Z, Kirshenbaum LA, Arnold M, Khokha R, Liu PP. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation. 2007;115:1398-1407. (Pubitemid 46648375)
35. Sanyal SN, Ono K. Derangement of autonomic nerve control in rat with right ventricular failure. Pathophysiology. 2002;8:197-203. (Pubitemid 34597212)
36. Leineweber K, Brandt K, Wludyka B, Beilfuss A, Ponicke K, Heinroth- Hoffmann I, Brodde OE. Ventricular hypertrophy plus neurohumoral activation is necessary to alter the cardiac beta-adrenoceptor system in experimental heart failure. Circ Res. 2002;91:1056-1062. (Pubitemid 35416643)